The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Dose of midazolam should be reduced during diltiazem and verapamil treatments.
Open accessAbstract
1. The effects of diltiazem and verapamil on the pharmacokinetics and pharmacodynamics of midazolam were investigated in a double‐blind randomized cross‐over study of three phases. 2. Nine healthy volunteers were given orally diltiazem (60 mg), verapamil (80 mg) or placebo three times daily for 2 days. On the second day they received a 15 mg oral dose of midazolam, after which plasma samples were collected and performance tests carried out for 17 h. 3. The area under the midazolam concentration‐time curve was increased from 12 +/‐ 1 microgram ml‐1 min to 45 +/‐ 5 micrograms ml‐1 min by diltiazem (P < 0.001) and to 35 +/‐ 5 micrograms ml‐1 min by verapamil (P < 0.001). The peak midazolam concentration was doubled (P < 0.01) and the elimination half‐life of midazolam prolonged (P < 0.05) by both diltiazem and verapamil treatments. 4. These changes in the pharmacokinetics of midazolam were also associated with profound and prolonged sedative effects. 5. If the administration of midazolam cannot be avoided, the dose of midazolam should be reduced during concomitant treatment with diltiazem and verapamil.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The use of analogue scales in rating subjective feelings
BOND, A., & LADER, M. (1974) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1974.tb02285.x · Cited by 1,972
Cited by
Dresser, G. K., Spence, J. D., & Bailey, D. G. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200038010-00003 · Cited by 908
IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3A
Thummel, K. E., & Wilkinson, G. R. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.389 · Cited by 831
Inhibition and Induction of Cytochrome P450 and the Clinical Implications
Lin, J. H., & Lu, A. Y. H. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199835050-00003 · Cited by 829
Bjornsson, T. D., Callaghan, J. T., Einolf, H. J., Fischer, V., Gan, L., Grimm, S., Kao, J., King, S. P., Miwa, G., Ni, L., et al. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.7.815 · Cited by 792
Adverse Sedation Events in Pediatrics: Analysis of Medications Used for Sedation
Coté, C. J., Karl, H. W., Notterman, D. A., Weinberg, J. A., & McCloskey, C. (2000) · Pediatrics · doi:10.1542/peds.106.4.633 · Cited by 616
Metadata
- Authors
- Backman, J., Olkkola, K., Aranko, K., Himberg, J., & Neuvonen, P.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1994-03
- Volume
- 37
- Issue
- 3
- Pages
- 221-225
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W2082314577
- Cited by
- 184
- References
- 1
- FWCI
- 6.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dose of midazolam should be reduced during diltiazem and verapamil treatments. https://app.cochat.ai/papers/10.1111/j.1365-2125.1994.tb04266.x
- The paper
- Backman, J., Olkkola, K., Aranko, K., Himberg, J., & Neuvonen, P. (1994). Dose of midazolam should be reduced during diltiazem and verapamil treatments. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.1994.tb04266.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.